Bezzio, Cristina http://orcid.org/0000-0003-0076-8549
Vernero, Marta
Costa, Stefania
Armuzzi, Alessandro
Fiorino, Gionata
Ardizzone, Sandro
Roselli, Jenny
Carparelli, Sonia
Orlando, Ambrogio
Caprioli, Flavio Andrea
Castiglione, Fabiana
Viganò, Chiara
Ribaldone, Davide G.
Zingone, Fabiana
Monterubbianesi, Rita
Imperatore, Nicola
Festa, Stefano
Daperno, Marco
Scucchi, Ludovica
Ferronato, Antonio
Pastorelli, Luca
Alimenti, Eleonora
Balestrieri, Paola
Ricci, Chiara
Cappello, Maria
Felice, Carla
Coppini, Francesca
Alvisi, Patrizia
Di Luna, Imma
Gerardi, Viviana
Variola, Angela
Mazzuoli, Silvia
Lenti, Marco Vincenzo
Saibeni, Simone
,
Pugliese, Daniela
Furfaro, Federica
Maconi, Giovanni
Milla, Monica
Bossa, Fabrizio
Giuliano, Alessandra
Piazza, Nicole
Manes, Gianpiero
Sartini, Alessandro
Buda, Andrea
Micheli, Federica
Ciardo, Valeria
Casella, Giovanni
Viscido, Angelo
Bodini, Giorgia
Casini, Valentina
Soriano, Alessandra
Amato, Arnaldo
Grossi, Laurino
Onali, Sara
Rottoli, Matteo
Spagnuolo, Rocco
Baroni, Stefania
Cortelezzi, Claudio
Baldoni, Monia
Vernero, Marta
Scaldaferri, Franco
Maconi, Giovanni
Guarino, Alessia
Palermo, Andrea
D’Incà, Renata
Scribano, Maria Lia
Biancone, Livia
Carrozza, Lucio
Ascolani, Marta
Costa, Francesco
Di Sabatino, Antonio
Zammarchi, Irene
Gottin, Matteo
Conforti, Francesco Simone
Article History
Received: 28 September 2022
Accepted: 30 May 2023
First Online: 5 July 2023
Declarations
:
: The study protocol was approved by the IG-IBD Scientific Committee and by the Ethics Committees of participating IBD centres from across Italy. A verbal consent was obtained from all participants. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.
: Not applicable.
: CB received lecture fees from Takeda, MSD and Janssen. AA served as a consultant for AbbVie, Allergan, Amgen, Biogen, Bristol Myers Squibb, Celgene, Celltrion, Ferring, Gilead, Janssen, Lilly, MSD, Mylan, Pfizer, Roche, Samsung Bioepis, Sandoz, and Takeda. FF, SA and MM received lecture fees from Janssen. AO served as a consultant for AbbVie, MSD, Janssen, Pfizer, Takeda, Sofar and Chiesi. FAC served as consultant and a member of advisory board for Mundipharma, AbbVie, MS&D, Takeda, Janssen, Roche and Celgene, received lecture fees from AbbVie, Amgen, Ferring, Takeda and Allergy Therapeutics and received unrestricted research grants from Giuliani, Sofar, MSD, Takeda and AbbVie. FC served as consultant and a member of the advisory board for Mundipharma, AbbVie, MSD, Takeda, Janssen, Roche and Celgene and received lecture fees from AbbVie, Amgen, Ferring, Takeda and Allergy Therapeutics. DR served as consultant and received lecture fees from Janssen, Ferring and Errekappa. FZ received lecture fees from Alphasigma, Takeda and Janssen. SF received consultancy fees from Sofar, Zambon, AbbVie and Takeda and is a member of advisory boards for Janssen Pharmaceuticals. MD served as a speaker, consultant and advisory board member for AbbVie, Takeda, Janssen, Norgine, Pfizer, MSD, Celltrion, Roche, Gilead, Bioclinica, Ferring, SOFAR, Chiesi and Zambon. LP served as a speaker, consultant and advisory board member for AbbVie, Takeda, Janssen, Biogen, Sandoz, Fresenius-Kabi and Eli Lilly. PB served as a speaker, consultant or advisory board member for Takeda and Janssen. CR reports personal fees from AbbVie, Janssen Cilag, MSD, Recordati, Takeda and Vifor. MC served as a speaker or advisory board member for Takeda, MSD, AbbVie, Shire, Fresenius and Janssen. CF served as consultant for Amgen. GF received consultancy fees from Ferring, MSD, AbbVie, Takeda, Janssen, Amgen, Sandoz, Samsung Bioepis and Celltrion. SS received lecture fees from Takeda Pharmaceuticals and Janssen Pharmaceuticals and served as a consultant and advisory board member for AbbVie and Janssen Pharmaceuticals.